Phase I/II Trial of Dendritic Cells Pulsed with Telomerase.
Angela Märten(Boehringer Ingelheim (United States)), Ingo G.H. Schmidt‐Wolf(University Hospital Bonn), Holger Strunk(University of Bonn), Peter Albers(Düsseldorf University Hospital), Christian Franchy, Tilman Sauerbruch(University Hospital Bonn), Stefan C. Müller(Johannes Gutenberg University Mainz), Alexander von Rücker(University of Bonn), Hans H. Schild(University of Bonn), Elisabeth Sievers(Karolinska University Hospital)
Cited by 0
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
|Journal of Clinical Oncology|2005|1.1k
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603
<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
|Journal of Clinical Oncology|2011|450